Home › Gastrointestinal Cancers › Texas › Irving
Gastrointestinal Cancers clinical trials in Irving, TX
3 studies for Gastrointestinal Cancers are looking for participants at sites in and around Irving (within about 30 miles). Open a study to see who can join and how to contact the study team.
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecruitingPhase 3
- US Oncology Investigational Products Center (IPC), Irving
- US Oncology Investigational Products Center, Irving
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
- NEXT Dallas, Irving
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RecruitingPhase 1/2
- NEXT Oncology Dallas, Irving
Gastrointestinal Cancers trials in other cities
- Houston, TX21 studies
- Boston, MA15 studies
- New York City, NY12 studies
- Nashville, TN10 studies
- Los Angeles, CA9 studies
- Durham, NC8 studies
- Dallas, TX8 studies
- Arlington, VA8 studies
- Baltimore, MD8 studies
- Cincinnati, OH8 studies
- San Antonio, TX7 studies
- Aurora, CO7 studies
Other studies in Irving
- Non-Small Cell Lung Cancer22 studies
- Cancer (all types)15 studies
- Colorectal Cancer13 studies
- Metastatic Cancer11 studies
- Pancreatic Cancer7 studies
- Stomach Cancer7 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Lung Cancer6 studies
- Small Cell Lung Cancer6 studies
- Breast Cancer6 studies
- Ovarian Cancer5 studies
- Triple-Negative Breast Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.